ODIN has reserved DKK 23.9 million for six new research projects that will pave the way for new drugs to treat a wide range of medical conditions. iNANO researchers Duncan Sutherland, Jørgen Kjems, and Daniel Otzen take part in these projects on Parkinson's disease, schizophrenia, diabetes, renal diseases and cancer.